Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) vs IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
Side-by-side comparison of two grants.
| Attribute | Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) | IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $4M |
| Deadline | Closes 2028-01-07 | Closes 2026-12-14 |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | researchers, students, government | nonprofits, researchers |
noindex — no measured search demand